These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2894771)

  • 61. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Insulin inhibits somatostatin-like immunoreactivity release stimulated by intragastric HCl.
    Rouiller D; Schusdziarra V; Unger RH
    Diabetes; 1981 Sep; 30(9):735-8. PubMed ID: 6114888
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Radioimmunoassay study of hepatic clearance and disappearance half-time of somatostatin and vasoactive intestinal peptide in dogs.
    Chayvialle JA; Rayford PL; Thompson JC
    Gut; 1981 Sep; 22(9):732-7. PubMed ID: 6117506
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Glucose ingestion in dogs alters the hepatic extraction of insulin. In vivo evidence for a relationship between biologic action and extraction of insulin.
    Jaspan J; Polonsky K
    J Clin Invest; 1982 Mar; 69(3):516-25. PubMed ID: 7037850
    [TBL] [Abstract][Full Text] [Related]  

  • 65. First-pass hepatic extraction and metabolic effects of insulin and insulin analogues.
    Chap Z; Ishida T; Chou J; Hartley CJ; Entman ML; Brandenburg D; Jones RH; Field JB
    Am J Physiol; 1987 Feb; 252(2 Pt 1):E209-17. PubMed ID: 3548421
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evidence for the presence of somatostatin 28 in plasma.
    Shoelson S; Polonsky K; Docherty H; Jaspan J; Rubenstein A
    Diabetes; 1982 May; 31(5 Pt 1):474-7. PubMed ID: 6130021
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hepatic extraction of bile salts in conscious dogs.
    Pries JM; Sherman CA; Williams GC; Hanson RF
    Am J Physiol; 1979 Feb; 236(2):E191-7. PubMed ID: 420289
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Glyburide increases the secretion, tissue uptake, and action of insulin in conscious normal dogs.
    Adrogue HJ; Pena J; Comstock JP
    Metabolism; 1996 May; 45(5):579-86. PubMed ID: 8622600
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Somatostatin concentration and binding in the rat hypothalamus and striatum during severe insulin-induced hypoglycemia.
    Rodriguez-Sanchez MN; Arilla E
    Biosci Rep; 1989 Apr; 9(2):199-206. PubMed ID: 2569898
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Degradation and conversion of somatostatin in normal and diabetic rats in vivo and in vitro.
    Seno M; Tsuda K; Kitano N; Takeda J; Fukumoto H; Koh G; Imura H; Taminato T; Seino Y
    Can J Physiol Pharmacol; 1988 Jan; 66(1):55-60. PubMed ID: 2897235
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Novel glucosensor for hypoglycemic detection localized to the portal vein.
    Hevener AL; Bergman RN; Donovan CM
    Diabetes; 1997 Sep; 46(9):1521-5. PubMed ID: 9287058
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hepatic and renal metabolism of somatostatin-like immunoreactivity. Simultaneous assessment in the dog.
    Polonsky KS; Jaspan JB; Berelowitz M; Emmanouel DS; Dhorajiwala J
    J Clin Invest; 1981 Nov; 68(5):1149-57. PubMed ID: 6117570
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Modulation of motilin-induced somatostatin release in dogs by naloxone.
    Schick R; Schusdziarra V
    Peptides; 1985; 6(5):861-4. PubMed ID: 2867525
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterization of somatostatin in peripheral and portal plasma in the duck: in-vivo metabolism of somatostatin-28 and -14.
    Di Scala-Guenot D; Strosser MT; Mialhe P
    J Endocrinol; 1984 Mar; 100(3):329-35. PubMed ID: 6142074
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetic approach to the estimation of hepatic removal of insulin.
    Berzins R; Tam YK; Molnar GD; Rajotte RV; Wieczorek KR; McGregor JR; Fawcett DM
    Pancreas; 1986; 1(6):544-9. PubMed ID: 3550790
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The kinetics of peritoneal insulin absorption.
    Schade DS; Eaton RP; Davis T; Akiya F; Phinney E; Kubica R; Vaughn EA; Day PW
    Metabolism; 1981 Feb; 30(2):149-55. PubMed ID: 7007802
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Quantitative aspects of insulin secretion and its hepatic and renal removal in sheep.
    Brockman RP; Bergman EN
    Am J Physiol; 1975 Nov; 229(5):1338-43. PubMed ID: 1200152
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of caerulein administration on portal plasma somatostatin in dogs.
    Kasanuki J; Fujimoto S; Makino H; Kanatsuka A; Imaizumi T; Koseki H; Kaneko R; Tokumasa Y; Yoshida S
    Gastroenterol Jpn; 1984 Jun; 19(3):221-6. PubMed ID: 6146548
    [TBL] [Abstract][Full Text] [Related]  

  • 79. On the accuracy of radioimmunological determination of somatostatin in plasma.
    Hilsted L; Holst JJ
    Regul Pept; 1982 Jun; 4(1):13-31. PubMed ID: 6126917
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ouabain hypoglycemia: insulin mediation.
    Triner L; Killian P; Nahas GG
    Science; 1968 Nov; 162(3853):560-1. PubMed ID: 4884353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.